Viral RNAs
Outwit the Immune System
Herpes viruses are pathogenic DNA viruses known for establishing
long-term latent infections. Some forms of herpes are sexually transmitted
diseases and lead to genital lesions. Others are known for leading to “fever
blisters” around the lips. Once the virus infects the cell, its viral genome is
transcribed into viral mRNA and other smaller RNA molecules, collectively known
as noncoding RNA or ncRNA. Some of the ncRNAs are very small, micro RNAs, while
others are longer at about 100 nucleotides.
Researchers studying a herpes virus called human cytomega-lovirus (HCMV) recently showed that one of the functions of the longer ncRNA from the virus was to allow the infected cells to evade the innate immunity response, as shown in the figure. RNAs make excellent weapons against the immune system. They are fast-acting because they do not need to be translated, and they are poor targets for the adaptive immune response.
HCMV is a
herpes virus that causes severe disease in newborn infants and
immunocompromised individuals. It encodes at least 2 long ncRNAs and 11 miRNAs.
Current research suggests that these two ncRNAs are immune-response inhibitors.
Within hours of HCMV infection, a 2.7-kb viral ncRNA (2.7)
accumulates, reaching 20% of the total viral RNA. This RNA binds to components
of the mitochondrial respiratory chain complex I (MRCC-I), stabilizing its
function as a countermeasure to apoptosis. Thus, b2.7
prevents the premature death of the infected cell and the steady production of
ATP during the viral life cycle. The virus also produces a miRNA, miR-UL112.
This miRNA inhibits the production of mRNA for a cell surface ligand that
attracts natural killer cells. Thus, these two RNA molecules inhibit the
destruction of the cell by NK cells as well as promoting the general strength
of the host cell to prevent cell death.
Related Topics
Privacy Policy, Terms and Conditions, DMCA Policy and Compliant
Copyright © 2018-2024 BrainKart.com; All Rights Reserved. Developed by Therithal info, Chennai.